164 related articles for article (PubMed ID: 34860291)
1. Resection of oesophageal and oesophagogastric junction cancer liver metastases - a summary of current evidence.
Weiss ARR; Donlon NE; Schlitt HJ; Hackl C
Langenbecks Arch Surg; 2022 May; 407(3):947-955. PubMed ID: 34860291
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial.
Shapiro J; van Lanschot JJB; Hulshof MCCM; van Hagen P; van Berge Henegouwen MI; Wijnhoven BPL; van Laarhoven HWM; Nieuwenhuijzen GAP; Hospers GAP; Bonenkamp JJ; Cuesta MA; Blaisse RJB; Busch ORC; Ten Kate FJW; Creemers GM; Punt CJA; Plukker JTM; Verheul HMW; Bilgen EJS; van Dekken H; van der Sangen MJC; Rozema T; Biermann K; Beukema JC; Piet AHM; van Rij CM; Reinders JG; Tilanus HW; Steyerberg EW; van der Gaast A;
Lancet Oncol; 2015 Sep; 16(9):1090-1098. PubMed ID: 26254683
[TBL] [Abstract][Full Text] [Related]
3. Surgery in oesophago-gastric cancer with metastatic disease: Treatment, prognosis and preoperative patient selection.
Schmidt T; Alldinger I; Blank S; Klose J; Springfeld C; Dreikhausen L; Weichert W; Grenacher L; Bruckner T; Lordick F; Ulrich A; Büchler MW; Ott K
Eur J Surg Oncol; 2015 Oct; 41(10):1340-7. PubMed ID: 26213358
[TBL] [Abstract][Full Text] [Related]
4. Successful curative surgery for postoperative oesophageal recurrence of oesophagogastric junction cancer.
Ikebe M; Kubo N; Fukuyama S; Yano T
BMJ Case Rep; 2020 Jul; 13(7):. PubMed ID: 32675117
[TBL] [Abstract][Full Text] [Related]
5. Liver metastases resection for gastric and esophageal tumors: is there enough evidence to go down this path?
Tapia Rico G; Townsend AR; Klevansky M; Price TJ
Expert Rev Anticancer Ther; 2016 Dec; 16(12):1219-1225. PubMed ID: 27744727
[TBL] [Abstract][Full Text] [Related]
6. Optimal therapeutic strategies for resectable oesophageal or oesophagogastric junction cancer.
Bystricky B; Okines AF; Cunningham D
Drugs; 2011 Mar; 71(5):541-55. PubMed ID: 21443280
[TBL] [Abstract][Full Text] [Related]
7. Oesophagectomy for carcinoma of the oesophagus and oesophagogastric junction.
Dalrymple-Hay MJ; Evans KB; Lea RE
Eur J Cardiothorac Surg; 1999 May; 15(5):626-30. PubMed ID: 10386408
[TBL] [Abstract][Full Text] [Related]
8. Variations among 5 European countries for curative treatment of resectable oesophageal and gastric cancer: A survey from the EURECCA Upper GI Group (EUropean REgistration of Cancer CAre).
Messager M; de Steur WO; van Sandick JW; Reynolds J; Pera M; Mariette C; Hardwick RH; Bastiaannet E; Boelens PG; van deVelde CJ; Allum WH;
Eur J Surg Oncol; 2016 Jan; 42(1):116-22. PubMed ID: 26461256
[TBL] [Abstract][Full Text] [Related]
9. New insights in the lymphatic spread of oesophageal cancer and its implications for the extent of surgical resection.
Cense HA; van Eijck CH; Tilanus HW
Best Pract Res Clin Gastroenterol; 2006; 20(5):893-906. PubMed ID: 16997168
[TBL] [Abstract][Full Text] [Related]
10. Defining a positive circumferential resection margin in oesophageal cancer and its implications for adjuvant treatment.
O'Neill JR; Stephens NA; Save V; Kamel HM; Phillips HA; Driscoll PJ; Paterson-Brown S
Br J Surg; 2013 Jul; 100(8):1055-63. PubMed ID: 23616367
[TBL] [Abstract][Full Text] [Related]
11. A randomized clinical trial of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the oesophagus or gastro-oesophageal junction.
Klevebro F; Alexandersson von Döbeln G; Wang N; Johnsen G; Jacobsen AB; Friesland S; Hatlevoll I; Glenjen NI; Lind P; Tsai JA; Lundell L; Nilsson M
Ann Oncol; 2016 Apr; 27(4):660-7. PubMed ID: 26782957
[TBL] [Abstract][Full Text] [Related]
12. [Surgical treatment of carcinomas of the oesophagogastric junction - results achieved in multicentre studies].
Steinert R; Gastinger I; Ridwelski K; Ptok H; Wolff S; Meyer F; Otto R; Lippert H
Zentralbl Chir; 2013 Aug; 138(4):403-9. PubMed ID: 23950077
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant chemoradiotherapy for resectable oesophageal and gastro-oesophageal junction cancer--do we need another randomised trial?
Hingorani M; Crosby T; Maraveyas A; Dixit S; Bateman A; Roy R
Clin Oncol (R Coll Radiol); 2011 Dec; 23(10):696-705. PubMed ID: 21684129
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant radio-chemotherapy of adenocarcinoma of the oesophagogastric junction.
Samel S; Hofheinz R; Hundt A; Sturm J; Knoll MR; Wenz F; Queisser W; Post S
Onkologie; 2001 Jun; 24(3):278-82. PubMed ID: 11455222
[TBL] [Abstract][Full Text] [Related]
15. Patients undergoing surgery for oligometastatic oesophageal cancer survive for more than 2 years: bootstrapping systematic review data.
Schizas D; Mylonas KS; Kapsampelis P; Bagias G; Katsaros I; Frountzas M; Hemmati P; Liakakos T
Interact Cardiovasc Thorac Surg; 2020 Sep; 31(3):299-304. PubMed ID: 32666121
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of the location of metastatic lymph nodes in patients with adenocarcinoma of the oesophagogastric junction.
Liu JF; Jiang T; Shi ZH; Liu XB
ANZ J Surg; 2018 Mar; 88(3):218-222. PubMed ID: 27444989
[TBL] [Abstract][Full Text] [Related]
17. Extent of oesophageal resection for adenocarcinoma of the oesophagogastric junction.
Mariette C; Castel B; Balon JM; Van Seuningen I; Triboulet JP
Eur J Surg Oncol; 2003 Sep; 29(7):588-93. PubMed ID: 12943624
[TBL] [Abstract][Full Text] [Related]
18. A randomised controlled trial to assess whether prehabilitation improves fitness in patients undergoing neoadjuvant treatment prior to oesophagogastric cancer surgery: study protocol.
Allen S; Brown V; Prabhu P; Scott M; Rockall T; Preston S; Sultan J
BMJ Open; 2018 Dec; 8(12):e023190. PubMed ID: 30580268
[TBL] [Abstract][Full Text] [Related]
19. The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction - a phase III trial of the German AIO/CAO-V/CAOGI.
Al-Batran SE; Goetze TO; Mueller DW; Vogel A; Winkler M; Lorenzen S; Novotny A; Pauligk C; Homann N; Jungbluth T; Reissfelder C; Caca K; Retter S; Horndasch E; Gumpp J; Bolling C; Fuchs KH; Blau W; Padberg W; Pohl M; Wunsch A; Michl P; Mannes F; Schwarzbach M; Schmalenberg H; Hohaus M; Scholz C; Benckert C; Knorrenschild JR; Kanngießer V; Zander T; Alakus H; Hofheinz RD; Roedel C; Shah MA; Sasako M; Lorenz D; Izbicki J; Bechstein WO; Lang H; Moenig SP
BMC Cancer; 2017 Dec; 17(1):893. PubMed ID: 29282088
[TBL] [Abstract][Full Text] [Related]
20. The decision to operate: role of integrated computed tomography positron emission tomography in staging oesophageal and oesophagogastric junction cancer by the multidisciplinary team.
Berrisford RG; Wong WL; Day D; Toy E; Napier M; Mitchell K; Wajed S
Eur J Cardiothorac Surg; 2008 Jun; 33(6):1112-6. PubMed ID: 18328726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
